Reaction
Graft Thrombosis reporting signals
As of the last recalculation, Graft Thrombosis appears in 261 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 179.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Basiliximab | 24 | 179.1 | 179.5 |
| Anti-Thymocyte Globulin (Rabbit) | 12 | 124.3 | 124.5 |
| Valganciclovir Hydrochloride Powder, | 13 | 89.4 | 89.5 |
| Heparin Sodium | 12 | 72.9 | 72.9 |
| Valganciclovir | 15 | 67.3 | 67.3 |
| Valganciclovir Hydrochloride | 15 | 67.3 | 67.3 |
| Sirolimus | 10 | 61.5 | 61.6 |
| Cinacalcet Hydrochloride | 7 | 12.3 | 12.3 |